Guy Vandenbussche Selected Research

norharman

1/2020	A new potential anti-cancer beta-carboline derivative decreases the expression levels of key proteins involved in glioma aggressiveness: A proteomic investigation.
6/2017	A harmine-derived beta-carboline displays anti-cancer effects in vitro by targeting protein synthesis.
6/2017	Data in support of a harmine-derived beta-carboline in vitro effects in cancer cells through protein synthesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Guy Vandenbussche Research Topics

Disease

4	Neoplasms (Cancer) 01/2020 - 04/2011
3	Glioma (Gliomas) 01/2020 - 04/2011
2	Melanoma (Melanoma, Malignant) 06/2017 - 11/2010
1	Alzheimer Disease (Alzheimer's Disease) 01/2018
1	Amyloidosis 03/2014
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2012
1	Prostatic Neoplasms (Prostate Cancer) 03/2011
1	Wounds and Injuries (Trauma) 05/2009
1	Infections 09/2006
1	Vesicular Stomatitis 09/2006

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 01/2020 - 05/2009
3	norharmanIBA 01/2020 - 06/2017
3	Cytostatic AgentsIBA 06/2017 - 11/2010
2	Harmine (Telepathine)IBA 06/2017 - 06/2017
1	Actin Depolymerizing Factors (Cofilins)IBA 01/2020
1	Protein Synthesis InhibitorsIBA 01/2020
1	ProteomeIBA 01/2020
1	Galectin 1 (LGALS1)IBA 01/2020
1	CholesterolIBA 01/2018
1	ApolipoproteinsIBA 01/2018
1	LipidsIBA 01/2018
1	Apolipoproteins E (ApoE)IBA 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 06/2017
1	Eukaryotic Initiation Factor-3IBA 06/2017
1	Peptides (Polypeptides)IBA 01/2012
1	Phosphorylcholine (Phosphocholine)IBA 01/2012
1	Surface-Active Agents (Surfactants)IBA 01/2012
1	Caveolin 1IBA 04/2011
1	IntegrinsIBA 04/2011
1	Temozolomide (Temodar)FDA LinkGeneric 04/2011
1	Ouabain (G Strophanthin)IBA 03/2011
1	narciclasineIBA 11/2010
1	LatexIBA 05/2009
1	Glycoproteins (Glycoprotein)IBA 09/2006

Therapy/Procedure

3	Therapeutics 01/2020 - 11/2010